Karl Ahlstedt

About the Author Karl Ahlstedt

Karl holds a degree in business management and studied post graduate investment management at a top UK university. He has since worked at some of the largest Welsh investment companies as an Investment Analyst and delivered guest lectures in Finance at the University of Wales.

Is It Time to Buy Cannabis Stock Tilray (TLRY)?

The performance of Tilray (TLRY) stock in recent months lags behind similarly sized competitors as aggregated revenues remain low and multiple minor headwinds …

Does Cannabis Stock Aphria (APHA) Have What It Takes?

With a market cap hovering at $3 billion, Aphria (APHA) remains one of the largest companies operating within the high-growth cannabis arena. So …

Aurora Cannabis (ACB) Stock Is a Wait-And-See Story

Founded in 2006 with circa $5 million in capital, Aurora Cannabis (ACB) expanded rapidly via acquisitions including Padanios, CanvasRx, and BC Northern Lights …

Cannabis Stock on Focus: Canopy Growth (CGC) – A Word of Caution

Canopy Growth (CGC) continues its acquisition spree by taking a minority stake of circa 25% in Seth Rogens “Houseplant” business according to High …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts